Rare Disease News

Staying Focused on What Really Matters About the ACA

Published November 4, 2013 by NORD

Categorized in -

Despite the current focus on logistical problems associated with the rollout of the Affordable Care Act, we must not forget that this law includes some important insurance reforms that were …

Continue reading “Staying Focused on What Really Matters About the ACA”

30 Years After the Orphan Drug Act: It Still Takes Too Long for People with Rare Diseases to Get an Accurate Diagnosis

Published October 23, 2013 by NORD

Categorized in -

NORD recently posted the following question on its Facebook page: How long did it take you or a loved one to get an accurate diagnosis? We were stunned at …

Continue reading “30 Years After the Orphan Drug Act: It Still Takes Too Long for People with Rare Diseases to Get an Accurate Diagnosis”

Enrollment in Your Health Insurance Marketplace

Published August 29, 2013 by NORD

Categorized in -

It seems like just yesterday the Supreme Court handed down its controversial decision to uphold much of President Obama’s monumental healthcare reform bill, the Affordable Care Act. But with …

Continue reading “Enrollment in Your Health Insurance Marketplace”

Supreme Court Decision Consistent With Longstanding NORD Position

Published June 14, 2013 by NORD

Categorized in -

Yesterday’s ruling by the U.S. Supreme Court that human genes are a product of nature and cannot be patented is being hailed by many as a victory for patients and …

Continue reading “Supreme Court Decision Consistent With Longstanding NORD Position”

Orphan Drug Act at 30: Will Success Become Too Expensive?

Published January 19, 2013 by NORD

Categorized in -

Reprinted with permission from FDA Matters: By Steven Grossman The Orphan Drug Act (ODA) turned 30 this month, demonstrating that good laws really can have an enduring impact. Amidst the …

Continue reading “Orphan Drug Act at 30: Will Success Become Too Expensive?”

NORD Issues Statement on the Death of Actor Jack Klugman

Published December 25, 2012 by NORD

Categorized in -

Jack Klugman touched the lives of millions of Americans through his support for what ultimately became the Orphan Drug Act. By portraying on his Quincy, M.E. television show the plight …

Continue reading “NORD Issues Statement on the Death of Actor Jack Klugman”

Campaign to Educate State Legislators for Rare Disease Day

Published December 14, 2012 by NORD

Categorized in -

Each year NORD provides a list of suggested activities for Rare Disease Day. This year, one of those major projects is a nationwide campaign to help leaders of rare disease …

Continue reading “Campaign to Educate State Legislators for Rare Disease Day”

Patients Will Benefit From New Public-Private Partnership

Published December 3, 2012 by NORD

Categorized in -

FDA Commissioner Margaret Hamburg, MD, today announced a new public-private partnership to develop regulatory science that will speed patient access to new medical device technologies. This is the first public-private …

Continue reading “Patients Will Benefit From New Public-Private Partnership”

Proposed Rules for Health Insurance Market Reforms and Essential Health Benefits

Published November 28, 2012 by NORD

Categorized in -

Advocacy

On November 20, 2012, the Centers for Medicare and Medicaid Services (CMS) released the long-awaited proposed rules for health insurance market reforms and essential health benefits. These provisions of the …

Continue reading “Proposed Rules for Health Insurance Market Reforms and Essential Health Benefits”

Rare Disease News

Access State Report Card Data